Since 2004, Medical Prognosis Institute, a Danish IT-Medico company, has developed a method to improve the diagnostics process and drug treatment of cancer patients. DRP, Drug Response Prediction, is a Companion Diagnostics-product which can predict which patients will respond to a drug and can also predict which disease or indication has the highest fraction of responders. Limiting the clinical trial population to those patients who are predicted to respond to a new drug dramatically increases the probability of successful phase III drug development.
Carsten Borring, Head of Listing and Capital Markets NASDAQ OMX Copenhagen said: “We are proud to welcome Medical Prognosis Institute to First North Copenhagen. MPI is a company with an interesting proposition and a company with international growth ambitions. Market conditions are improving and we hope MPI will benefit from having the First North-platform as a point of departure for meeting new investors and partners.”
Peter Buhl Jensen, CEO of Medical Prognosis Institute said:” Having MPI admitted to trading on First North is a stamp of approval towards international partners and works to highlight the company’s potential to investors and other stakeholders. Since 2004, MPI has gone through a remarkable transformation from being a research heavy company to now having a product on the market. I would like to thank existing shareholders for the support and look forward to welcoming new investors."
Certified Advisor is Carsten Yde Hemme, PricewaterhouseCoopers
About First North
First North is regulated as an alternative marketplace operated by the NASDAQ OMX Copenhagen within NASDAQ OMX Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
About NASDAQ OMX Group
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-55 microsecond speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world’s securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,300 listed companies worth more than $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit www.nasdaqomx.com. Follow us on Facebook (www.facebook.com/NASDAQ) and Twitter (www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500)
| Media Relations Contact: + Javier Lopez Garrido + +4533770430 + javier.lopez@nasdaqomx.com |
